Promoters hold 51.9% of Aurobindo Pharma Limited (AUROPHARMA). FIIs hold 16.4%, mutual funds 16.7% and other DIIs 8.4%. 13.8% of the promoter holding is pledged. Quarterly shareholding, quarter ended Jun 26.
Folio counts aren't part of the shareholding pattern we ingest today — they arrive with a later filing parse.
| Holder | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 51.9% | 51.8% | 51.8% | 51.8% | 51.8% | 51.8% | 51.8% | 51.8% | 51.8% | 51.8% | 51.8% | 51.8% |
| FII | 16.4% | 15.2% | 13.9% | 14.2% | 14.4% | 15.3% | 16.3% | 16.6% | 16.7% | 18.0% | 20.7% | 22.4% |
| MF | 16.7% | 17.8% | 19.5% | 19.3% | 19.0% | 18.2% | 17.8% | 18.5% | 19.2% | 17.8% | 14.7% | 11.3% |
| Other DII | 8.4% | 8.1% | 8.2% | 8.3% | 8.0% | 8.0% | 7.4% | 6.6% | 5.6% | 5.5% | 5.9% | 7.0% |
| Retail & others | 6.6% | 7.1% | 6.5% | 6.4% | 6.9% | 6.6% | 6.7% | 6.5% | 6.7% | 6.9% | 6.8% | 7.4% |
| Pledge | 13.8% | 23.6% | 17.5% | 17.5% | 17.1% | — | — | — | — | — | — | — |
No bulk or block deals disclosed for this stock in the last 90 days.
Bulk deals are uncommon for large caps — a single client has to trade over 0.5% of the company's shares in one day. Most weeks, none happen.
No PIT or SAST disclosures on record for this stock in the last 12 months.
That is the usual state — promoters, directors and holders above 5% file only when they trade or pledge; a new filing appears here within a day of reaching the exchange.
Promoters hold 51.88% as of Jun 26, with 13.8% pledged; institutional ownership was broadly unchanged this quarter.
Quarterly shareholding patternas of Jun 26
